A federal court has entered a $3,423,389.84 default judgment against a Nebraska pharmacist and pharmacy operator over alleged false claims submitted to Medicare and Medicaid.
The U.S. District Court for the District of Nebraska entered the judgment May 29 against Joan Kicken and AME P.C., doing business as Campbell Drug, after it had failed to defend against allegations brought by the federal government, according to a June 8 Justice Department news release.
The government alleged that Ms. Kicken owned and operated Campbell Drug in Oshkosh, Neb., and submitted fraudulent billings to Medicare and Medicaid. The complaint alleged the pharmacy sought reimbursement from Medicaid for prescription drugs without valid prescriptions, billed for prescription drugs that were never dispensed and sought reimbursement for brand-name medications while dispensing generic versions.
Federal prosecutors filed the complaint Oct. 31, 2025, alleging the conduct was intended to generate improper financial gain. The case was investigated with support from the HHS Office of the Inspector General and the Nebraska Medicaid Fraud and Patient Abuse Unit.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
